All Posts by

Leslie Merryman

Exposure to Air Pollutants and Lewy Body and Parkinson Disease–Related Dementias

New JAMA Publication! Congratulations to Dimitry S. Davydow, MD, MPH, Gregory M. Pontone, MD, MHS, Michael S. Okun, MD, and Melissa J. Armstrong, MD on their publication “Exposure to Air Pollutants and Lewy Body and Parkinson Disease–Related Dementias,” which appears in JAMA Open Network. Long-term exposure to common air pollutants may increase the risk of developing Parkinson’s disease-related dementia and…

Real-World Safety and Effectiveness of 24-Hour Foslevodopa/Foscarbidopa in Parkinson’s Disease: ROSSINI Study 6-Month Interim Results

Congratulations Dr. Irene Malaty Dr. Malaty research “Real-World Safety and Effectiveness of 24-Hour Foslevodopa/Foscarbidopa in Parkinson’s Disease: ROSSINI Study 6-Month Interim Results,” was published in the May 2026 issue of Neurology and Therapy. Abstract Foslevodopa/foscarbidopa (LDp/CDp) is a nonsurgical 24-h continuous subcutaneous infusion for patients with advanced Parkinson’s disease (aPD)…

Diffusion MRI and α‐Synuclein Seed Amplification Status in Parkinson’s Disease

New Publication! Congratulations to Drs. Melissa J Armstrong, Nikolaus R. McFarland, Michael Okun and David Vaillancourt on the publication of “Diffusion MRI and α‐Synuclein Seed Amplification Status in Parkinson’s Disease,” which appears in the May edition of Annals of Neurology. Abstract Objective Positive α‐synuclein seed amplification assay (SAA) is a…

Unveiling Reporting & Representation of Race and Ethnicity in Acute Interventional Neurology Trials: A Systematic Review

Congratulations on your new publication! Congratulations to Hector David Meza Comparan, Luciola Frota, Michael Mathelier, Carolina Maciel and Katharina Busl on the publication of “Unveiling Reporting & Representation of Race and Ethnicity in Acute Interventional Neurology Trials: A Systematic Review,” which appears in the April 8th edition of Neurology. Abstract Objective:…

UF Research Foundation names 2026 UFRF Professors

The University of Florida Research Foundation, or UFRF, has recognized 34 faculty members as UFRF Professors for 2026, including five from the College of Medicine. Honorees are selected in recognition of a strong track record of research excellence and their work to advance discovery, creativity and innovation across the university.

Alzheimer’s & Brain Awareness Month event

Join us on June 10th In honor of Alzheimer’s & Brain Awareness Month, attend this event in the UF Health Shands Hospital Atrium for a special day of brain health, Alzheimer’s and dementia awareness and education. Worldwide, 55 million people are living with Alzheimer’s and other dementias. The Alzheimer’s Association…

Music-based rhythm improves gait in Parkinson’s patients

Whether it’s the simple tick of a metronome or the thumping bassline in a disco classic, not all beats are created equal. A University of Florida Health research team that tested how rhythmic cues influence walking found that both those with Parkinson’s disease and healthy older adults demonstrated improved gait…

World MS Day!

While Multiple Sclerosis (MS) Awareness Month is observed in March, we recognize World MS Day on May 30 to honor individuals around the world living with MS, as well as their families and caregivers. Learn more about our MS & Neuroimmunology Disorders Clinic at Fixel. Learn more about The My…

Safety and efficacy of the anti-α-synuclein monoclonal antibody amlenetug for the treatment of patients with multiple system atrophy (AMULET): a phase 2, randomised, double-blind, multicentre trial

Congratulations on your new publication! Congratulations to Dr. Nikolaus McFarland on the publication of “Safety and efficacy of the anti-α-synuclein monoclonal antibody amlenetug for the treatment of patients with multiple system atrophy (AMULET): a phase 2, randomised, double-blind, multicentre trial,” which appears in the April edition of The Lancet. Summary…